Simvastatin treatment reduces the cholesterol content of membrane/lipid rafts, implicating the N -methyl-D-aspartate receptor in anxiety: a literature review

Authors

  • Júlia Niehues da Cruz Instituto Dante Pazzanese de Cardiologia image/svg+xml
  • Débora Delwing Dal Magro Universidade Regional de Blumenau image/svg+xml
  • Daniela Delwing de Lima Universidade da Região de Joinville image/svg+xml
  • José Geraldo Pereira da Cruz Universidade Regional de Blumenau image/svg+xml

DOI:

https://doi.org/10.1590/s2175-97902017000116102

Keywords:

Anxiolytic effects, Membrane/lipid rafts, N-methyl-D-aspartate, Simvastatin.

Abstract

Membrane/lipid rafts (MLRs) are plasmalemmal microdomains that are essential for neuronal signaling and synaptic development/stabilization. Inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase (statins) can disable the N-methyl-D-aspartate (NMDA) receptor through disruption of MLRs and, in turn, decrease NMDA-mediated anxiety. This hypothesis will contribute to understanding the critical roles of simvastatin in treating anxiety via the NMDA receptor.

Downloads

Download data is not yet available.

References

Downloads

Published

2017-01-01

Issue

Vol. 53 No. 1 (2017)

Section

Review

License

All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.

The on-line journal has open and free access.

How to Cite

Simvastatin treatment reduces the cholesterol content of membrane/lipid rafts, implicating the N -methyl-D-aspartate receptor in anxiety: a literature review. (2017). Brazilian Journal of Pharmaceutical Sciences, 53(1), e16102-. https://doi.org/10.1590/s2175-97902017000116102